Canine parvovirus antigen (CPV Ag)

Catalog No.

FSCPVAGF

Specimen

Feces

Dimensions

Height: 80mm, Length: 300mm

Product Description

  1. INTENDED USE

The CPV Ag Rapid Test is a fluorescence-based immunoassay designed for the qualitative detection of Canine Parvovirus (CPV) antigen in canine feces or vomitus. This rapid diagnostic tool assists veterinarians in:

  • Early and accurate diagnosis of acute CPV infection (especially in puppies and unvaccinated dogs)
  • Differentiating parvovirus enteritis from other causes of hemorrhagic gastroenteritis
  • Monitoring disease progression and therapeutic efficacy during treatment
  • Supporting timely isolation decisions to prevent outbreaks in kennels or shelters

Note: For veterinary use only. Results should be interpreted in conjunction with clinical signs and vaccination history.

  1. TEST PRINCIPLE

The test utilizes a sandwich fluorescence immunoassay format with the following mechanism:

  1. Sample Application: The diluted fecal sample migrates via capillary action along the test strip.
  2. Antigen Capture: CPV antigens bind to anti-CPV monoclonal antibodies conjugated with fluorescent nanoparticles.
  3. Complex Formation: The antigen-antibody complex is captured by immobilized anti-CPV antibodies at the test line.
  4. Signal Generation: Accumulation of fluorescent nanoparticles produces a measurable signal when excited by the reader.
  5. Result Interpretation: The portable fluorescence analyzer provides:
    • Qualitative result (Positive/Negative) within 5-8 minutes
    • Semi-quantitative index (fluorescence intensity ratio) indicating viral load

Key Performance Characteristics:

  • High Sensitivity: Detects CPV-2 variants (2a, 2b, 2c) with ≥98% agreement to PCR
  • Minimal Hook Effect: Accurate detection even at high antigen concentrations (up to 10⁶ TCID₅₀/mL)
  • Reduced Interference: Fluorescence technology minimizes false positives from bloody/hemolyzed samples

For optimal results:

  • Use fresh fecal samples (<24h old) or properly stored at 2-8°C
  • Follow recommended dilution protocols for formed/vomitus samples
  • Confirm negative results in clinically suspicious cases with PCR testing

related Products